Gene News and Research

Latest Gene News and Research

Scientists suggest that Oprl1 receptor is altered in mice with PTSD-like symptoms

When injected into mice immediately following a traumatic event, a new drug prevents the animals from developing memory problems and increased anxiety that are indicative of post-traumatic stress disorder.

6 Jun 2013

Researchers provide insights into potential therapeutic approaches to Down syndrome

University of Michigan researchers have determined how a gene that is known to be defective in Down syndrome is regulated and how its dysregulation may lead to neurological defects, providing insights into potential therapeutic approaches to an aspect of the syndrome.

6 Jun 2013

Cells with amplified HER2 gene need to be considered carefully, study says

Biocept, Inc., a privately-held, CLIA certified laboratory testing company focused on detection and analysis of circulating tumor cells and circulating tumor DNA in cancer patients, reported the publication in the journal Cancer Medicine of a paper entitled "Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer" on research performed with collaborators from the University of Texas MD Anderson Cancer Center.

5 Jun 2013

Research demonstrates need for development of new treatments for regeneration of nerve cells

Researchers at the University of Michigan have evidence that a single gene controls both halves of nerve cells, and their research demonstrates the need to consider that design in the development of new treatments for regeneration of nerve cells.

5 Jun 2013

Study suggests modulation of "enhancer-directed RNAs" can alter gene expression in living cells

In a pair of distinct but complementary papers, researchers at the University of California, San Diego School of Medicine and colleagues illuminate the functional importance of a relatively new class of RNA molecules.

5 Jun 2013

Research: RG3039 drug can extend survival, improve function in spinal muscular atrophy mouse models

In a new publication that appears in Human Molecular Genetics, the laboratory of Christine DiDonato, PhD reports on their pharmacological characterization of the drug RG3039, demonstrating that it can extend survival and improve function in two spinal muscular atrophy (SMA) mouse models.

5 Jun 2013

EORTC BOS 2 trial to test efficacy of adding bevacizumab to peri-operative FOLFOX 4 chemotherapy

Colorectal cancer (CRC) is the second most frequent cause of cancer-related mortality in both Europe and the United States. Treatment for patients with resectable hepatic metastases from colorectal cancer consists of surgery combined with chemotherapy, but recurrence is observed in two thirds of these patients.

5 Jun 2013

Thomson Reuters announces this year's Hottest Researchers

The Intellectual Property & Science business of Thomson Reuters today announced this year's Hottest Researchers, a ranking of the most influential scientific researchers and research papers on ScienceWatch, the open web resource for science metrics and analysis.

5 Jun 2013

Better understanding of breast milk variability, strategies for optimizing neonatal diet

The composition of breast milk varies from mother to mother, and genetic factors may affect the levels of protective components in breast milk that could influence a newborn's outcomes.

5 Jun 2013

Stem cells that strongly express WNT3 are biased to develop into cells and tissues, say researchers

According to researchers at Boston Children's Hospital, stem cells that strongly express a gene called WNT3 are biased to develop into cells and tissues including pancreas, liver and bladder.

5 Jun 2013

Blocking MHCII action rescues nerve cells from Parkinson's disease mechanisms, researchers find

The same mechanism that lets the immune system mount a massive attack against invading bacteria contributes to the destruction of brain cells as part of Parkinson's disease, according to a study published online today in the Journal of Neuroscience.

5 Jun 2013

UCLA researchers identify abnormal brain networks in Fragile X syndrome

The genetic malady known as Fragile X syndrome is the most common cause of inherited autism and intellectual disability. Brain scientists know the gene defect that causes the syndrome and understand the damage it does in misshaping the brain's synapses - the connections between neurons. But how this abnormal shaping of synapses translates into abnormal behavior is unclear.

5 Jun 2013

Duke researchers find novel way to repair gene responsible for Duchenne muscular dystrophy

Using a novel genetic 'editing' technique, Duke University biomedical engineers have been able to repair a defect responsible for one of the most common inherited disorders, Duchenne muscular dystrophy, in cell samples from Duchenne patients.

5 Jun 2013

Research provides insights into potential new strategies to detect, treat and prevent breast cancer

New research provides critical insights into how normal breast precursor cells may be genetically vulnerable to develop into cancer. The research is published June 4th in the inaugural issue of Stem Cell Reports, an open-access journal from the International Society of Stem Cell Research published by Cell Press.

5 Jun 2013

Canadian researcher develops first animal model to study function of C9ORF72 in ALS

Canadian researcher Edor Kabashi of the Université de Montréal has developed the first animal model to study the function of a gene responsible for the highest percentage of ALS, commonly known as Lou Gehrig's disease. Results to date shed light on the cause of the devastating disease.

4 Jun 2013

Diaxonhit, XDx agree to market and perform AlloMap Molecular Expression Testing in Europe

Diaxonhit, the leading French provider of specialty diagnostic solutions, and XDx, Inc., a U.S. molecular diagnostics company focused on non-invasive tests for transplantation and autoimmune disease, announced today that they have entered into a memorandum of agreement for the exclusive license to market and perform AlloMap Molecular Expression Testing (AlloMap) in Europe.

4 Jun 2013

Researchers establish link between abnormal structure of synapses and behavioral abnormalities of brain circuits in FXS

Fragile X syndrome (FXS) is a genetic malady that is the most common inherited cause of autism and intellectual disability. Brain scientists know the gene defect that causes FXS, and the damage it does-- misshaping the brain's synapses, the connections between neurons. But how that abnormal shaping of synapses translates to abnormal behavior is unclear.

4 Jun 2013

Gene expression test measures risk of metastases in breast cancer patients

In Austria every year approx. 1,500 postmenopausal patients, that is, after the climacteric period, are affected by stage II breast cancer. This means that in these women tumour cells have already been found in the lymph nodes and that the risk of metastases appearing in the future course of the illness is significantly increased.

4 Jun 2013

Study brings researchers one step closer to personalized colorectal cancer treatment

MET protein levels correlate strongly with epithelial-mesenchymal transition phenotype, a treatment-resistant type of colorectal cancer and may be used as a surrogate biomarker, according to new research from The University of Texas MD Anderson Cancer Center.

4 Jun 2013

Researchers now one step closer to unlocking the nature of ALS

As the result of a major breakthrough by researchers at Northwestern University's School of Medicine, researchers studying amyotrophic lateral sclerosis, commonly known as Lou Gehrig's Disease, are now one step closer to unlocking the nature of ALS.

4 Jun 2013

Gene News and Research

Latest Gene News and Research

Scientists suggest that Oprl1 receptor is altered in mice with PTSD-like symptoms

Researchers provide insights into potential therapeutic approaches to Down syndrome

Cells with amplified HER2 gene need to be considered carefully, study says

Research demonstrates need for development of new treatments for regeneration of nerve cells

Study suggests modulation of "enhancer-directed RNAs" can alter gene expression in living cells

Research: RG3039 drug can extend survival, improve function in spinal muscular atrophy mouse models

EORTC BOS 2 trial to test efficacy of adding bevacizumab to peri-operative FOLFOX 4 chemotherapy

Thomson Reuters announces this year's Hottest Researchers

Better understanding of breast milk variability, strategies for optimizing neonatal diet

Stem cells that strongly express WNT3 are biased to develop into cells and tissues, say researchers

Blocking MHCII action rescues nerve cells from Parkinson's disease mechanisms, researchers find

UCLA researchers identify abnormal brain networks in Fragile X syndrome

Duke researchers find novel way to repair gene responsible for Duchenne muscular dystrophy

Research provides insights into potential new strategies to detect, treat and prevent breast cancer

Canadian researcher develops first animal model to study function of C9ORF72 in ALS

Diaxonhit, XDx agree to market and perform AlloMap Molecular Expression Testing in Europe

Researchers establish link between abnormal structure of synapses and behavioral abnormalities of brain circuits in FXS

Gene expression test measures risk of metastases in breast cancer patients

Study brings researchers one step closer to personalized colorectal cancer treatment

Researchers now one step closer to unlocking the nature of ALS

Industry focus eBook - Cell and gene therapy (2nd edition) eBook

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care